This article argues that advances in nanotechnology in general, and lab-on-chip technology in particular, have the potential to benefit the developing world in its quest to control risks to human health and the environment. Based on the “risk society” thesis of Ulrich Beck, it is argued that the developed world must realign its science and technology policy priorities to meet some of the most pressing needs of humanity.
Beck, U. (1992). Risk society: Towards a new modernity. London: Sage.
2.
Beck, U. (1995a). Ecological enlightenment: Essays on the politics of the risk society. Atlantic Highlands, NJ: Humanities.
3.
Beck, U. (1995b). Ecological politics in an age of risk. Cambridge, UK: Polity.
4.
Broerse, J.E.W., & Bunders, J.F.G. (2005). Agricultural biotechnology and developing countries: Issues of poverty alleviation, food security, and sustainable development. In M. D. Mehta (Ed.), Biotechnology unglued: Science, society and social cohesion (pp. 27-50). Vancouver: University of British Columbia Press.
5.
Chin, C.D., Linder, V., & Sia, S.K. (2007). Lab-on-a-chip devices for global health: Past studies and future opportunities. Lab Chip, 7, 41-57.
6.
Clift, R. (2006). Risk management and regulation in an emerging technology. In G. Hunt& M. Mehta (Eds.), Nanotechnology: Risk, ethics and law (pp. 140-153). London: Earthscan .
7.
Durant, J. (1998). Once the men in white coats held the promise of a better future. In F. Franklin (Ed.), The politics of risk society (pp. 70-75). Cambridge, UK: Polity.
8.
ETC Group. (2006). Nanotech Rx: Medical applications of nanoscale technologies. What impact on marginalized communities?Ottawa, ON: Author . Available from http://www.etcgroup.org
9.
Gascoyne, P., Satayavivad, J., & Ruchirawat, M. (2004). Microfluidic approaches to malaria detection. Acta Tropica, 89(3), 357-369.
10.
Howard, C.V., & Ikah, D.S.K. (2006). Nanotechnology and nanoparticle toxicity: A case for precaution. In G. Hunt & M. Mehta (Eds.), Nanotechnology: Risk, ethics and law (pp. 154-166). London: Earthscan.
11.
Mehta, M.D. (2005). Risk, reflexive modernity and the unbinding of politics: Agricultural biotechnology in a globalized world. In S. Hewa & D. Stapleton (Eds.), Globalization, philanthropy, and civil society: Toward a new political culture in the 21st century (pp. 193-204). New York: Springer.
12.
Mehta, M.D., & Hunt, G. (2006). What makes nanotechnologies special? In G. Hunt & M. Mehta (Eds.), Nanotechnology: Risk, ethics and law (pp. 274-281). London: Earthscan.
13.
Mehta, M.D., & Poudrier, J. (2004). Microfluidic platforms, genetic databases, and biosociality. In G. Arnason, S. Nordal, & V. Arnason (Eds.), Blood and data: Ethical, legal and social aspects of human genetic databases (pp. 17-22). Reykjavik: University of Iceland Press.
14.
Pilarski, L., Mehta, M.D., Caulfield, T., Kaler, K.V.I. S., & Backhouse, C.J. (2004). Microsystems and nanoscience for biomedical applications: A view to the future. Bulletin of Science, Technology & Society, 24(1): 40-45.
United Nations Programme on HIV/AIDS & World Health Organization. (2006). AIDS epidemic update. Retrieved November 21, 2006, from http://www.unaids.org/en/HIV%5Fdata/epi2006/
17.
World Health Organization. (2004). Waterborne zoonoses: Identification, causes and control. Retrieved January 28, 2007, from http://www.who.in/entity/water_sanitation_health/diseases/zoonoses.pdf
18.
Yager, P., Edwards, T., Fu, E., Helton, K., Nelson, K., Tam, M.R., et al. (2006). Microfluidic diagnostic technologies for global public health. Nature, 442, 412-418.
